Wave Life Sciences CFO Sells Shares Under Trading Plan
| Reporter Name | Moran Kyle |
| Relationship | Chief Financial Officer |
| Type | Sell |
| Amount | $96,421 |
| SEC Filing | Form 4 |
Wave Life Sciences Ltd.'s Chief Financial Officer, Kyle Moran, sold 15,630 ordinary shares on April 3, 2024, for a total of $96,421. The sale was conducted at a weighted-average price of $6.169 per share, with prices ranging from $6.115 to $6.23. This transaction was executed under a Rule 10b5-1 trading plan adopted on November 21, 2023. Following this sale, Moran directly owns 33,921 ordinary shares of the company. The ownership includes 3,431 shares acquired under the company's 2019 Employee Share Purchase Plan.
SEC Filing: Wave Life Sciences Ltd. [ WVE ] - Form 4 - Apr. 05, 2024